Skip to main content

Table 3 Number of eligible patients and number of times a selected procedure was performed in eligible patients.

From: Payment for performance (P4P): any future in Italy?

  Hospital N.1 Hospital N.2 Hospital N.3
  N. of times the selected procedure is performed in eligible patients N. of eligible patients N. of times the selected procedure is performed in eligible patients N. of eligible patients N. of times the selected procedure is performed in eligible patients N. of eligible patients
1. Aspirin prescribed at discharge 390 460 323 345 262 305
2. Beta-blocker prescribed at discharge 376 460 249 345 200 305
3. Adult smoking cessation advice/counseling 16 139    2 46
4. LDL cholesterol assessment 73 460 48 345 1 305
5. Lipid lowering therapy at discharge 376 460 256 345 219 305
6. Inpatient mortality 38 498     
7. Evaluation of left ventricular systolic (LVS) function (LVF Assessment) 1049 1590 663 1277 314 575
8. ACEI or ARB for left ventricular systolic dysfunction (LVSD) 1059 1590 909 1277 352 575
9. Adult smoking cessation advice/counseling 22 145    6 33
10. Thrombolytic therapy administered 15 347 6 420 0 172
11. Discharged on cholesterol reducing medication 74 347 174 420 37 172
12. Smoking cessation advice/counseling 4 33    8 10
13. Recommended Venous Thromboembolism (VTE) Prophylaxis Ordered 169 182 0 533 24 200